Previous 10 | Next 10 |
home / stock / cvs / cvs articles
Humana Inc (NYSE:HUM) shares nosedived after the company released dismal fourth quarter 2023 earnings. The company reported a Q4 adjusted...
The two investments will reduce the company's carbon footprint by nearly 114,000 metric tons annually WOONSOCKET, R.I., Jan. 25, 2024 /PRNewswi...
The Federal Reserve is driving the market bus. Rate cut expectations have been re-drawn, and the “buy everything” sentiment that powere...
Healthcare insurance firm Humana Inc (NYSE:HUM) cut its fiscal 2023 earnings outlook as the costs of members’ care exceeded its exp...
In the current market session, CVS Health Inc. (NYSE:CVS) share price is at $76.58, after a 2.98% drop. Over the past month, the stock went up by 0...
CVS Health Corp (NYSE:CVS) is reportedly looking to close some of its pharmacies located within Target Corporation (NYSE:TGT) s...
The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and affo...
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as di...
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 06:35:00 ET CVS Health (NYSE: CVS) is a top pharmacy retailer in the U.S., and over the years, it has been expanding its operations to go deeper into healthcare. The stock also provides investors with a dividend that yields 4.3%, which is more than double the S&P 50...
2024-06-27 21:02:00 ET CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since November 2020. Pharmacy woes are continuing The pharmacy...
2024-06-20 08:00:10 ET Andrew Mok from Barclays issued a price target of $65.00 for CVS on 2024-06-20 07:01:00. The adjusted price target was set to $65.00. At the time of the announcement, CVS was trading at $61.01. The overall price target consensus is at $109.15 with ...